Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHAFEEQ S LADHA

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neuromuscular Medicine

NPI
1417931767
CMS profile
290565
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$131,204.52

80 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Genentech USA, Inc. $48,381.59 26
GENZYME CORPORATION $32,693.04 11
SANOFI-AVENTIS U.S. LLC $26,537.08 6
Biogen, Inc. $10,554.53 11
Amicus Therapeutics, Inc. $5,887.00 4
UCB, Inc. $2,652.30 12
Genentech, Inc. $1,775.90 5
Amylyx Pharmaceuticals, Inc. $1,602.61 3
SANOFI US SERVICES INC. $1,092.00 1
Alexion Pharmaceuticals, Inc. $28.47 1

Page 2 of 2; records 51–80 of 80 matching records. This page contains 30 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHAFEEQ S LADHA

NPI 1417931767 · CMS profile ID 290565

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neuromuscular Medicine

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–80 of 80 matching records. This page contains 30 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1417931767?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHAFEEQ S LADHA, NPI 1417931767, CMS profile ID 290565. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–80 of 80 matching records. This page contains 30 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1417931767?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). SHAFEEQ S LADHA, NPI 1417931767, CMS profile ID 290565. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–80 of 80 matching records. This page contains 30 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1417931767?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
SHAFEEQ S LADHA, NPI 1417931767, CMS profile ID 290565, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–80 of 80 matching records. This page contains 30 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1417931767?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

80 matching records · $131,204.52 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 80 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–80 of 80.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Genentech USA, Inc. $30.0004/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550691 CMS
Genentech USA, Inc. $5,520.0004/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550695 CMS
Biogen, Inc. $153.0004/10/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012277137 CMS
Genentech USA, Inc. $2,070.0003/28/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550711 CMS
Amylyx Pharmaceuticals, Inc. $59.2203/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057676947 CMS
Biogen, Inc. $23.1403/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012246373 CMS
GENZYME CORPORATION $93.8903/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050011427 CMS
UCB, Inc. $9.2403/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021730183 CMS
UCB, Inc. $26.0103/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021730195 CMS
UCB, Inc. $50.0003/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021730201 CMS
Genentech USA, Inc. $5,520.0003/15/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550609 CMS
Genentech USA, Inc. $869.7903/15/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550617 CMS
Genentech USA, Inc. $147.8103/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550627 CMS
Genentech USA, Inc. $23.3503/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550783 CMS
UCB, Inc. $130.0002/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021730225 CMS
UCB, Inc. $1,125.0002/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021730249 CMS
SANOFI US SERVICES INC. $1,092.0002/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050011419 CMS
Genentech, Inc. $194.6102/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550823 CMS
Genentech, Inc. $195.4002/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550791 CMS
Genentech, Inc. $140.1302/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550799 CMS
Genentech, Inc. $919.1902/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550807 CMS
Genentech, Inc. $326.5702/09/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040550815 CMS
GENZYME CORPORATION $876.0002/07/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050011531 CMS
UCB, Inc. $135.0001/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021730231 CMS
Biogen, Inc. $146.0001/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012268675 CMS
Biogen, Inc. $146.0001/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012208667 CMS
Biogen, Inc. $210.0001/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012219393 CMS
Biogen, Inc. $77.7501/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012232143 CMS
Biogen, Inc. $438.0001/12/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012279109 CMS
Biogen, Inc. $7,356.0001/11/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012272897 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $104,006.40 101
PY2020 $49,640.64 50
PY2021 $62,807.41 34
PY2022 $75,184.16 55
PY2023 $131,204.52 80
PY2024 $79,655.98 53
PY2025 $37,634.70 38

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $145,115.68 30
PY2024 Principal investigator $212,033.82 11
PY2023 Recipient $750.00 2
PY2023 Principal investigator $230,512.56 37
PY2022 Recipient $4,250.00 7
PY2022 Principal investigator $90,320.50 23
PY2021 Recipient $4,250.00 10
PY2021 Principal investigator $454,768.27 40
PY2020 Recipient $2,007.32 10
PY2020 Principal investigator $391,160.35 35
PY2019 Recipient $4,807.76 16
PY2019 Principal investigator $402,228.19 47

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

30 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GENZYME CORPORATION $1,313.71 12/22/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
PASS to Assess Long-term Safety in Patients with Pompe disease in the Commercial Setting No dispute reported 06/30/2026 1226143549
Principal investigator 1 Genentech, Inc. $336.00 12/10/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555731
Principal investigator 1 Genentech, Inc. $834.00 12/10/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555737
Principal investigator 1 SANOFI US SERVICES INC. $1,075.00 11/05/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
Pompe Disease Registry No dispute reported 06/30/2026 1226143564
Principal investigator 1 Genentech, Inc. $3,050.00 10/22/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555733
Principal investigator 1 GENZYME CORPORATION $3,325.00 10/20/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
PASS to Assess Long-term Safety in Patients with Pompe disease in the Commercial Setting No dispute reported 06/30/2026 1226143513
Principal investigator 1 Genentech, Inc. $703.85 08/20/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555893
Principal investigator 1 SANOFI US SERVICES INC. $5,100.00 08/01/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
Pompe Disease Registry No dispute reported 06/30/2026 1226143521
Principal investigator 1 Genentech, Inc. $610.00 07/16/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555888
Principal investigator 1 Genentech, Inc. $2,660.00 06/18/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555872
Principal investigator 1 Genentech, Inc. $112.00 06/18/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555877
Principal investigator 1 SANOFI US SERVICES INC. $425.00 05/07/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
Pompe Disease Registry No dispute reported 06/30/2026 1226143568
Principal investigator 1 Genentech, Inc. $4,731.00 04/23/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555727
Principal investigator 1 Genentech, Inc. $4,731.00 04/23/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555881
Principal investigator 1 Corcept Therapeutics $474.00 04/22/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
CORT113176-652 No dispute reported 06/30/2026 1214164045
Principal investigator 1 Corcept Therapeutics $7,977.12 04/15/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
CORT113176-652 No dispute reported 06/30/2026 1214164041
Principal investigator 1 SANOFI US SERVICES INC. $1,500.00 04/11/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
Pompe Disease Registry No dispute reported 06/30/2026 1226143574
Principal investigator 1 Genentech, Inc. $2,660.00 04/02/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555723
Principal investigator 1 Genentech, Inc. $2,660.00 04/02/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555884
Principal investigator 1 Genentech, Inc. $610.00 03/27/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555719
Principal investigator 1 Corcept Therapeutics $1,064.00 03/18/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
CORT113176-652 No dispute reported 06/30/2026 1214164037
Principal investigator 1 Corcept Therapeutics $2,012.00 02/18/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
CORT113176-652 No dispute reported 06/30/2026 1214164029
Principal investigator 1 Corcept Therapeutics $2,500.00 02/18/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
CORT113176-652 No dispute reported 06/30/2026 1214164033
Principal investigator 1 Genentech, Inc. $665.00 02/12/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
Phase 2 Trial of Neoadjuvant Atezo Platinum based Certolizumab in Patients w Lung Cancers No dispute reported 06/30/2026 1211555715
Principal investigator 1 Genentech, Inc. $3,407.00 02/12/2025 Covered Recipient Teaching Hospital
St. Rose Dominican - Siena
LONG TERM FOLLOW UP STUDY OF PATIENTS WITH SPINAL MUSCULAR ATROPHY RECEIVING RISDIPLAM TREATMENT No dispute reported 06/30/2026 1211555868
Principal investigator 1 SANOFI US SERVICES INC. $7,200.00 02/12/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
Pompe Disease Registry No dispute reported 06/30/2026 1226143307
Principal investigator 1 SANOFI US SERVICES INC. $1,500.00 01/29/2025 Covered Recipient Teaching Hospital
Mercy General Hospital
Pompe Disease Registry No dispute reported 06/30/2026 1226143381
Principal investigator 1 Biogen, Inc. $800.00 01/27/2025 Non-covered Recipient Entity
Barrow Neurological Institute-Main Hospital Entrance
A Phase 1 Multiple-Ascending-Dose Study to Assess the Safety,Tolerability, and Pharmacokinetics of BIIB105 Administered Intrathecally to AdultsWith Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in theAtaxin-2 Gene No dispute reported 06/30/2026 1236947778
Principal investigator 1 Corcept Therapeutics $4,959.00 01/21/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
CORT113176-652 No dispute reported 06/30/2026 1214164025
Principal investigator 1 Biogen, Inc. $76,121.00 01/07/2025 Covered Recipient Teaching Hospital
St. Josephs Hospital & Medical Ctr
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam No dispute reported 06/30/2026 1236947282